pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
BioPharma Dive·6h ago·1 min read
save

CVS agrees to $315 million settlement over alleged improper opioid prescriptions

Oct 14, 2026·read at BioPharma Dive ↗RegulatoryNegative

CVS Pharmacy has agreed to pay $315 million to settle federal allegations that it dispensed unnecessary opioid prescriptions.

The Justice Department claims the company filled prescriptions that were medically unnecessary and also sought Medicare reimbursement for them, violating Medicare rules.

CVS did not admit wrongdoing; a company spokesperson said the pharmacists are trained on safe medication use and that CVS strongly disagrees with the allegations, expressing relief to move past the litigation.

source

This writeup was produced by pharmadog from original reporting by BioPharma Dive.

Original headline: “CVS to pay $315M to settle opioid prescribing allegations”

read at BioPharma Dive ↗
531 words · retrieved 52m ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
AMICUS THERAPEUTICS, INC.
drugs
OXYCODONE HYDROCHLORIDEOXYCONTIN

related stories

  • Sep 30Kratom and 7-OH should be regulated, experts agree. They’re split on howSTAT
  • Aug 27A state gave sheriffs 20% of its opioid settlement cash. We followed the moneySTAT
  • Jun 18Super-potent synthetic opioids called nitazenes are spreading across the U.S.STAT
  • May 1‘Forever chemicals’ in baby formula? Scientists unpack FDA resultsSTAT
  • May 1STAT+: OxyContin maker Purdue Pharma set to dissolve after judge approves its criminal sentenceSTAT